Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024

-- Five posters to be presented at ObesityWeek® --

BOSTON, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 5:00 p.m. ET on Tuesday, November 5, 2024 to report its third quarter 2024 financial results and provide a corporate update. The conference call will be hosted live from The Obesity Society’s Annual Meeting, ObesityWeek® in San Antonio, TX.

To access the live conference call, participants may register here. While not required, it is recommended that participants join the call ten minutes prior to the scheduled start. A webcast of the call will also be available under "Events and Presentations" in the Investor Relations section of the Rhythm Pharmaceuticals website at http://ir.rhythmtx.com/. The archived webcast will be available on Rhythm’s website approximately two hours after it concludes and will be available for 30 days following the call.

The Company also announced today that Rhythm and its collaborators will deliver five poster presentations at The Obesity Society’s Annual Meeting, ObesityWeek®, which is being held November 3-6, 2024 in San Antonio, TX. All Rhythm or setmelanotide-related posters are scheduled to be presented on Tuesday, November 5:

• Weight Loss at 18 Months of Setmelanotide in 2- to